The UK Supreme Court Ruled Against Pfizer in Drug Patent Case
Resilinc-blog

According to Reuters, the UK Supreme Court rejected an appeal by Pfizer Inc. on Wednesday, November 14, regarding its patent for the use of Lyrica, known generically as pregabalin, in the treatment of neuropathic pain.

Read All Global Disruptions

Recent Global Disruptions